Type 2 diabetes: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes

  NCT07890376· Eli Lilly and Company· Source

• Decreasing Cardiovascular Risk for Patients With Diabetes

  NCT04874116· Michigan State University· Source

• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· Eli Lilly and Company· Source

• Food As MedicinE for Diabetes

  NCT04828785· University of North Carolina, Chapel Hill· Source

• A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  NCT07783802· Eli Lilly and Company· Source

• A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  NCT07881432· Eli Lilly and Company· Source

• A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07881458· Eli Lilly and Company· Source

• Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine

  NCT07148713· University of North Carolina, Chapel Hill· Source

• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  NCT07784725· AstraZeneca· Source

• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  NCT07662109· AstraZeneca· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Organoids 1
• Mendelian Randomization Analysis 56
• Gene Expression Profiling 38
• Sequence Analysis, RNA 2
• Proteomics 23
• Metabolomics 69
• Mass Spectrometry 34
• Flow Cytometry 12
• Immunohistochemistry 47
• Xenograft Model Antitumor Assays 34
• Positron-Emission Tomography 21
• Magnetic Resonance Imaging 29
• Machine Learning 18
• Deep Learning 1
• Cohort Studies 641
• Genome-Wide Association Study 100

See which targets of this disease your abstract mentions, and go to the people working on them.